This inventor holds 2 USPTO granted patents. Top assignee: Ucb S.a.. Active years: 2000-2001.
Company Filing History:
Years Active: 2000-2001
Title: The Innovations of Tongchuan Li
Introduction
Tongchuan Li is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of pharmacology, particularly in the development of nicotine cholinergic receptor agonists. With a total of 2 patents, his work has implications for therapeutic treatments.
Latest Patents
Among his latest patents is "Epibatidine and derivatives thereof as nicotine cholinergic receptor agonists." This invention provides methods of treatment utilizing pharmaceutical compositions that include an effective nicotine agonist amount of epibatidine or a synthetic derivative. Another significant patent is "Epibatidine and derivatives thereof as cholinergic receptor agonists," which further explores the applications of epibatidine in pharmacological treatments.
Career Highlights
Tongchuan Li is associated with UCB S.A., a company known for its focus on biopharmaceuticals. His work at UCB S.A. has allowed him to contribute to innovative solutions in the medical field.
Collaborations
Some of his notable coworkers include Changgeng Qian and Tesfaye Biftu. Their collaborative efforts have likely enhanced the research and development processes within their projects.
Conclusion
Tongchuan Li's contributions to the field of pharmacology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.